Separation of mediastinal shed blood during aortic valve surgery elicits a reduced inflammatory response
暂无分享,去创建一个
J. Morgan | F. Cheema | G. Bisleri | C. Muneretto | T. Bordonali | A. Repossini | F. Rosati | O. Siddiqui | L. Tononi
[1] H. Muhammad,et al. Effect of ulinastatin on perioperative organ function and systemic inflammatory reaction during cardiac surgery: a randomized double-blinded study , 2013, Korean journal of anesthesiology.
[2] Gang Wang,et al. Combined treatment of ulinastatin and tranexamic acid provides beneficial effects by inhibiting inflammatory and fibrinolytic response in patients undergoing heart valve replacement surgery. , 2013, The heart surgery forum.
[3] R. Whistance,et al. The Inflammatory Response to Miniaturised Extracorporeal Circulation: A Review of the Literature , 2010, Mediators of inflammation.
[4] Yasuhiko Kobayashi,et al. Minimal cardiopulmonary bypass attenuates neutrophil activation and cytokine release in coronary artery bypass grafting , 2007, Journal of Artificial Organs.
[5] O. Ponzio,et al. Comparison of the inflammatory response between miniaturized and standard CPB circuits in aortic valve surgery. , 2006, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[6] A. Markewitz,et al. Pro-inflammatory cytokines after different kinds of cardio-thoracic surgical procedures: is what we see what we know? , 2005, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[7] E. Kunesch,et al. Evaluation of coated oxygenators in cardiopulmonary bypass systems and their impact on neurocognitive function , 2005, Perfusion.
[8] O. Ponzio,et al. Reduction of the inflammatory response following coronary bypass grafting with total minimal extracorporeal circulation. , 2002, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[9] T. Yau,et al. Cardiopulmonary bypass induced inflammation: pathophysiology and treatment. An update. , 2002, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.
[10] X. Bossuyt,et al. Phosphorylcholine coating offers natural platelet preservation during cardiopulmonary bypass , 2002, Perfusion.
[11] M. Underwood,et al. Inflammatory response after coronary revascularization with or without cardiopulmonary bypass. , 2000, The Annals of thoracic surgery.
[12] K. Taylor,et al. Effects of cardiopulmonary bypass on leukocyte and endothelial adhesion molecules. , 1998, The Annals of thoracic surgery.
[13] A. Serraf,et al. Interleukin-10 release related to cardiopulmonary bypass in infants undergoing cardiac operations. , 1996, The Journal of thoracic and cardiovascular surgery.
[14] D. Mann,et al. Expression and functional significance of tumor necrosis factor receptors in human myocardium. , 1995, Circulation.
[15] J. Jespersen,et al. Enhanced Effective Fibrinolysis following the Neutralization of Heparin in Open Heart Surgery Increases the Risk of Post-Surgical Bleeding , 1990, Thrombosis and Haemostasis.
[16] Xiang Xiaoyong,et al. Cardiopulmonary bypass induced inflammation: pathophysiology and treatment , 2005 .
[17] D. Shale,et al. Effect of cardiopulmonary bypass on systemic release of neutrophil elastase and tumor necrosis factor. , 1993, The Journal of thoracic and cardiovascular surgery.
[18] E. Merrill,et al. Does the conformation of adsorbed fibrinogen dictate platelet interactions with artificial surfaces? , 1986, Blood.